Wenfeng Tan
300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Efficacy of Subcutaneous Firsekibart in Gout: A Phase Ib/II Clinical Trial.
Journal: International journal of rheumatic diseases
Published: October 17, 2025
Tripartite motif containing 21 autoimmunity primes CD8+ cell-mediated lung inflammation: an in vivo model of interstitial lung disease pathogenesis.
Journal: Arthritis research & therapy
Published: July 24, 2025
Clinical and molecular characterization of ILD in patients with overlapping ASyS and SjD: a retrospective observational study.
Journal: Rheumatology (Oxford, England)
Published: June 18, 2025
2025 Chinese guideline for the imaging diagnosis and evaluation of Takayasu arteritis.
Journal: Advances in rheumatology (London, England)
Published: January 15, 2025
Anti-MDA5 antibody IgG1 subtype is associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis.
Journal: Orphanet journal of rare diseases
Published: December 19, 2024
Analysis of clinical features of ruccrent interstitial lung disease in patients with anti-EJ positive antisynthetase syndrome
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: December 18, 2024
AdipoR1 promotes pathogenic Th17 differentiation by regulating mitochondrial function through FUNDC1.
Journal: Journal of biomedical research
Published: November 07, 2024
Low-input deep learning platform for citrullinated peptide identification, autoantigen discovery and rheumatoid arthritis treatment stratification.
Journal: Nature biomedical engineering
Published: August 19, 2024
Gut microbiome and metabolomics in systemic sclerosis: feature, link and mechanisms.
Journal: Frontiers in immunology
Published: August 04, 2024
Low serum S100A6 levels are associated RP-ILD risk in anti-MDA5-positive dermatomyositis.
Journal: Clinical rheumatology
Published: June 18, 2024
Triple-combination therapy did not improve prognosis in anti-MDA5 positive dermatomyositis: a multicentre longitudinal cohort study.
Journal: Clinical and experimental rheumatology
Published: May 12, 2024
Prognostic analysis of MDA5-associated clinically amyopathic dermatomyositis with interstitial lung disease.
Journal: Immunity, inflammation and disease
Published: January 31, 2024
Last Updated: 09/26/2026